Won‐Myong Bahk

4.5k total citations
214 papers, 3.0k citations indexed

About

Won‐Myong Bahk is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Won‐Myong Bahk has authored 214 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Psychiatry and Mental health, 65 papers in Pharmacology and 40 papers in Clinical Psychology. Recurrent topics in Won‐Myong Bahk's work include Bipolar Disorder and Treatment (97 papers), Schizophrenia research and treatment (66 papers) and Treatment of Major Depression (59 papers). Won‐Myong Bahk is often cited by papers focused on Bipolar Disorder and Treatment (97 papers), Schizophrenia research and treatment (66 papers) and Treatment of Major Depression (59 papers). Won‐Myong Bahk collaborates with scholars based in South Korea, United States and Italy. Won‐Myong Bahk's co-authors include Young Sup Woo, Chi‐Un Pae, Tae‐Youn Jun, Hee Ryung Wang, Jeong‐Ho Chae, Bo-Hyun Yoon, Duk‐In Jon, Jeong‐Ho Chae, Roger S. McIntyre and Sheng‐Min Wang and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and International Journal of Molecular Sciences.

In The Last Decade

Won‐Myong Bahk

197 papers receiving 2.9k citations

Peers

Won‐Myong Bahk
Jess G. Fiedorowicz United States
Malcolm Hopwood Australia
Trisha Suppes United States
Tom Bschor Germany
Ajeet Singh Australia
Jess G. Fiedorowicz United States
Won‐Myong Bahk
Citations per year, relative to Won‐Myong Bahk Won‐Myong Bahk (= 1×) peers Jess G. Fiedorowicz

Countries citing papers authored by Won‐Myong Bahk

Since Specialization
Citations

This map shows the geographic impact of Won‐Myong Bahk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won‐Myong Bahk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won‐Myong Bahk more than expected).

Fields of papers citing papers by Won‐Myong Bahk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won‐Myong Bahk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won‐Myong Bahk. The network helps show where Won‐Myong Bahk may publish in the future.

Co-authorship network of co-authors of Won‐Myong Bahk

This figure shows the co-authorship network connecting the top 25 collaborators of Won‐Myong Bahk. A scholar is included among the top collaborators of Won‐Myong Bahk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won‐Myong Bahk. Won‐Myong Bahk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Seung‐Hoon, Won‐Myong Bahk, Soo-Jung Lee, et al.. (2024). The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting. Clinical Psychopharmacology and Neuroscience. 22(2). 370–375.
2.
Woo, Young Sup, et al.. (2024). Defining “High Recurrence” of Depressive Episodes for Predicting Diagnostic Conversion from Major Depressive Disorder to Bipolar Disorder: A 5-year Retrospective Study. Clinical Psychopharmacology and Neuroscience. 22(2). 364–369. 1 indexed citations
3.
Yoon, Bo-Hyun, et al.. (2023). Psychometric properties of the Korean version of functioning assessment short test in bipolar disorder. Neuroscience Applied. 2. 103918–103918.
4.
Lee, Kyung Ho, Won‐Myong Bahk, Soo-Jung Lee, et al.. (2023). Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting. Clinical Psychopharmacology and Neuroscience. 21(3). 594–598.
5.
Woo, Young Sup, et al.. (2023). Prevalence and Comorbidities of Adult Attention-deficit/hyperactivity Disorder in a Community Sample from Korea. Clinical Psychopharmacology and Neuroscience. 21(4). 798–807. 2 indexed citations
6.
Wang, Sheng‐Min, et al.. (2023). Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials. Clinical Psychopharmacology and Neuroscience. 22(2). 222–231. 7 indexed citations
7.
Kim, Sun‐Young, Young‐Eun Jung, Kwang‐Hun Lee, et al.. (2023). Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study. Psychiatry Investigation. 21(1). 28–36. 1 indexed citations
8.
Woo, Young Sup, et al.. (2022). Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study. Clinical Psychopharmacology and Neuroscience. 20(3). 567–572. 3 indexed citations
10.
Jung, Young‐Eun, et al.. (2022). Sex Differences in COVID-19 Infection Fear in a Community Sample of Korean Adults Using Quantile Regression. Journal of Korean Medical Science. 38(4). e17–e17. 1 indexed citations
11.
Jon, Duk‐In, et al.. (2022). Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea. Clinical Psychopharmacology and Neuroscience. 20(1). 126–134. 27 indexed citations
12.
Woo, Young Sup, Won‐Myong Bahk, Jong‐Hyun Jeong, et al.. (2022). Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary. Clinical Psychopharmacology and Neuroscience. 20(4). 747–761. 7 indexed citations
13.
Kang, Kwi Young, et al.. (2021). Relationship between Handgrip Strength and Low-grade Inflammation in Older Adults with Depression. Clinical Psychopharmacology and Neuroscience. 19(4). 721–730. 5 indexed citations
14.
Shim, Se-Hoon, Yong‐Ku Kim, Young Hwangbo, et al.. (2021). The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder. Clinical Psychopharmacology and Neuroscience. 19(2). 334–340. 3 indexed citations
15.
Wang, Sheng‐Min, et al.. (2021). Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis. Clinical Psychopharmacology and Neuroscience. 19(2). 341–354. 38 indexed citations
16.
Woo, Young Sup, Won‐Myong Bahk, Young‐Min Park, et al.. (2021). Korean Medication Algorithm Project for Depressive Disorder 2021 (I): Treatment Strategies for Major Depressive Episode. Journal of Korean Neuropsychiatric Association. 60(3). 174–174. 2 indexed citations
17.
Wang, Sheng‐Min, et al.. (2020). Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis. Clinical Psychopharmacology and Neuroscience. 18(3). 423–433. 10 indexed citations
18.
Jung, Young‐Eun, Moon-Doo Kim, Won‐Myong Bahk, et al.. (2019). Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings. Clinical Psychopharmacology and Neuroscience. 17(3). 369–376. 5 indexed citations
19.
Jung, Young‐Eun, Moon-Doo Kim, Won‐Myong Bahk, et al.. (2016). Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS). BMC Psychiatry. 16(1). 239–239. 2 indexed citations
20.
Park, Min-Hyeon, et al.. (2007). Clinical Characteristics of Early Onset Bipolar Disorder : A Retrospective Chart Review Study. JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION. 46(5). 469–474. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026